RBC Capital Mkts resumed coverage on Danaher with a new price target
$DHR
Industrial Machinery/Components
Industrials
RBC Capital Mkts resumed coverage of Danaher with a rating of Outperform and set a new price target of $200.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/11/2026 | $200.00 | Neutral | Piper Sandler |
| 6/3/2026 | $210.00 | Buy | DZ Bank |
| 6/2/2026 | Peer Perform | Wolfe Research | |
| 5/26/2026 | $230.00 | Buy | Citigroup |
| 5/15/2026 | $200.00 | Outperform | RBC Capital Mkts |
| 12/9/2025 | $265.00 | Buy | Goldman |
| 12/2/2025 | $270.00 | Overweight | Morgan Stanley |
| 10/8/2025 | $220.00 | Buy → Neutral | Rothschild & Co Redburn |
4 - DANAHER CORP /DE/ (0000313616) (Issuer)
4 - DANAHER CORP /DE/ (0000313616) (Issuer)
4 - DANAHER CORP /DE/ (0000313616) (Issuer)
Piper Sandler initiated coverage of Danaher with a rating of Neutral and set a new price target of $200.00
DZ Bank initiated coverage of Danaher with a rating of Buy and set a new price target of $210.00
Wolfe Research resumed coverage of Danaher with a rating of Peer Perform
WASHINGTON, July 21, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) today announced results for the second quarter 2026. All results in this release reflect only continuing operations and period-to-period comparisons are year-over-year unless otherwise noted. Key Second Quarter 2026 ResultsNet earnings were $870 million, or $1.23 per diluted common share, up 60% year-over-year.Non-GAAP adjusted diluted net earnings per common share grew 8.0% to $1.94.Revenues increased 5.5% year-over-year to $6.3 billion.Non-GAAP core revenue increased 3.0% year-over-year and non-GAAP core revenue excluding respiratory testing revenue increased 4.5% year-over-year.Operating cash flow was $1.5 billion an
Linden Capital Partners ("Linden") and Audax Private Equity ("Audax"), two leading middle-market private equity firms, announced today an agreement to sell StatLab Medical Products ("StatLab" or the "Company") to Leica Biosystems, an operating company of Danaher Corporation (NYSE:DHR). The transaction is subject to customary closing conditions. Founded in 1976 and headquartered in McKinney, Texas, StatLab is a leading manufacturer of pre-analytical products spanning the full anatomic pathology workflow, delivering high-quality products and expert service to laboratories and OEM customers across the United States and Europe. During the ownership of Audax and Linden, StatLab expanded from a
WASHINGTON, June 29, 2026 /PRNewswire/ -- The Danaher Foundation, supported by Danaher Corporation (NYSE:DHR), today announced a $1 million commitment to support urgent, on-the-ground response to the Ebola Bundibugyo outbreak in the Democratic Republic of Congo (DRC) and Uganda through Save the Children, the International Rescue Committee (IRC) and the World Food Program USA in support of the World Food Programme (WFP). The funding will be distributed across the three organizations to enable rapid, flexible response to evolving conditions on the ground. Efforts will focus on critical needs including infection prevention, hygiene support, community-based health services and emergency food ass
8-K - DANAHER CORP /DE/ (0000313616) (Filer)
11-K - DANAHER CORP /DE/ (0000313616) (Filer)
S-8 - DANAHER CORP /DE/ (0000313616) (Filer)
WASHINGTON, July 21, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) today announced results for the second quarter 2026. All results in this release reflect only continuing operations and period-to-period comparisons are year-over-year unless otherwise noted. Key Second Quarter 2026 ResultsNet earnings were $870 million, or $1.23 per diluted common share, up 60% year-over-year.Non-GAAP adjusted diluted net earnings per common share grew 8.0% to $1.94.Revenues increased 5.5% year-over-year to $6.3 billion.Non-GAAP core revenue increased 3.0% year-over-year and non-GAAP core revenue excluding respiratory testing revenue increased 4.5% year-over-year.Operating cash flow was $1.5 billion an
WASHINGTON, June 22, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2026 on Tuesday, July 21, 2026 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the company will discuss its financial performance, as well as future expectations. The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations." A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available until the next quarterly earnings call.You can
WASHINGTON, June 10, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR), a global science and technology innovator, announced today that it has completed the acquisition of Masimo Corporation, a leading specialty diagnostics provider of pulse oximetry and other patient monitoring solutions, primarily in acute care treatment settings. Masimo's trusted brand, advanced sensor technology and AI-enabled patient monitoring bring complementary and powerful new capabilities to the Danaher diagnostics portfolio. As a result of the transaction, Masimo is now a wholly-owned subsidiary of Danaher and Masimo common stock has ceased trading on the Nasdaq Stock Market. Masimo will continue to operate unde
NEW YORK, June 8, 2026 /PRNewswire/ -- Sirius XM Holdings Inc. (NASD: SIRI) will replace Masimo Corp. (NASD: MASI) in the S&P MidCap 400 effective prior to the opening of trading on Thursday, June 11. S&P 500 & 100 constituent Danaher Corp. (NYSE:DHR) is acquiring Masimo in a deal expected to be completed soon pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date:Effective Date Index Name Action Company Name Ticker GICS Sector June 11, 2026 S&P MidCap 400 Addition Sirius XM HoldingsSIRI Communication Services June 11, 2026 S&P MidCap 400 Deletion MasimoMASI Health Care ABOUT S&P DOW JONES INDICESS&P Dow Jon
WASHINGTON, Feb. 17, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR), a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo Corporation (NASDAQ:MASI) a leading specialty diagnostics provider of pulse oximetry and other patient monitoring solutions, primarily in acute care settings. Under the terms of the agreement, Danaher will acquire all of the outstanding shares of Masimo common stock for $180 per share in cash, or a total enterprise value of approximately $9.9 billion including assumed indebtedness and net of acquired cash. This represents a transaction multiple of approximately 18x estimated 2027 EBITDA, or 15x 2
Leverages Mr. Ittmann's extensive print industry and international business experience Padraig Finn, with over 16 years in the print industry, promoted to Senior Vice President, Product Identification Tom Carll, Senior Vice President, Aerospace, Thomas DeByle, CFO, and Michael Natalizia, Chief Technology Officer, round out the Executive Leadership Team Darius G. Nevin appointed Executive Chairman AstroNova, Inc. (NASDAQ:ALOT), a leading innovator in specialized print technology solutions that enable data visualization, today announced that the Board of Directors has promoted Jorik E. Ittmann to President and CEO and appointed him to the Board of Directors, both to be effective
SC 13G/A - DANAHER CORP /DE/ (0000313616) (Subject)
SC 13G/A - DANAHER CORP /DE/ (0000313616) (Subject)
SC 13D/A - DANAHER CORP /DE/ (0000313616) (Subject)